Health

The costs of making things in space — and getting them back to earth — is high. But infrastructure to bring down the costs is being built.

The decline of cleantech and hydrogen investments is overstated in H1, according to GCV data, while transport investments go cold.

Outpatient surgery can be up to 60% cheaper and produce better outcomes than hospital procedures, but the market is fragmented. Oliver Keown wants to fix that.

Some 46 corporate-backed startups had an exit in May, a handful at more than $1bn. But the market is still in a holding pattern.

Leaps by Bayer's head of healthcare venture investments, Lucio Iannone, is set to be managing director for diabetes-focused VC investor The T1D Fund.

Rehau New Ventures invests in mobility, manufacturing, medtech, raw materials and the built world.

Eba leaves founding partner position to take on a CFO role.

CFO Javier Rodriguez is taking Owen Lozman's place as co-head of Merck's corporate VC unit, where he will lead its technology investments.

The foundation backs Georgia Institute of Technology's spinouts in areas including medtech, robotics, AI, marketplaces and defence.

Returns are great. Scaled innovations that move the needle are better.

Fresh from leading Cathay Capital's healthcare division, Hongjie Hu has joined Novo's investment arm as a growth-stage partner.